Y Song

Y Song serves as the CEO of Link Health Group since August 2012, leading initiatives that include securing four licenses for cases in China and Asia-Pacific, as well as facilitating five global collaborations for new drug development, resulting in significant funding and a pipeline of ten class 1 new drugs. Previously, Y Song held the position of General Manager at Guangzhou Anson Pharmaceutical from March 2014 to January 2015, focusing on business development. Additionally, Y Song was the International Business Director at Guangzhou Boji Pharmaceutical Service Group from January 2010 to March 2012, where responsibilities included international business development. Y Song holds a PhD in Biomedical Engineering with a specialization in Tissue Engineering and a Master's degree in Biomaterials, both earned from the University of Twente.